nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftriaxone—GLUL—epilepsy syndrome	0.422	0.908	CbGaD
Ceftriaxone—ALB—Oxcarbazepine—epilepsy syndrome	0.0448	0.153	CbGbCtD
Ceftriaxone—ALB—epilepsy syndrome	0.043	0.0924	CbGaD
Ceftriaxone—ALB—Fosphenytoin—epilepsy syndrome	0.0392	0.134	CbGbCtD
Ceftriaxone—ALB—Clonazepam—epilepsy syndrome	0.0354	0.121	CbGbCtD
Ceftriaxone—ALB—Rufinamide—epilepsy syndrome	0.0289	0.0986	CbGbCtD
Ceftriaxone—SLC22A8—Valproic Acid—epilepsy syndrome	0.0283	0.0968	CbGbCtD
Ceftriaxone—SLC22A6—Acetazolamide—epilepsy syndrome	0.0264	0.0902	CbGbCtD
Ceftriaxone—ALB—Phenytoin—epilepsy syndrome	0.0252	0.0862	CbGbCtD
Ceftriaxone—ALB—Propofol—epilepsy syndrome	0.0235	0.0804	CbGbCtD
Ceftriaxone—ALB—Diazepam—epilepsy syndrome	0.0213	0.0728	CbGbCtD
Ceftriaxone—SLC22A6—Valproic Acid—epilepsy syndrome	0.0197	0.0674	CbGbCtD
Ceftriaxone—GLUL—ganglion—epilepsy syndrome	0.00174	0.145	CbGeAlD
Ceftriaxone—GLUL—hindbrain—epilepsy syndrome	0.00132	0.11	CbGeAlD
Ceftriaxone—GLUL—brainstem—epilepsy syndrome	0.000758	0.0629	CbGeAlD
Ceftriaxone—GLUL—forebrain—epilepsy syndrome	0.000732	0.0607	CbGeAlD
Ceftriaxone—GLUL—telencephalon—epilepsy syndrome	0.000673	0.0558	CbGeAlD
Ceftriaxone—GLUL—medulla oblongata—epilepsy syndrome	0.000529	0.0438	CbGeAlD
Ceftriaxone—GLUL—midbrain—epilepsy syndrome	0.000483	0.0401	CbGeAlD
Ceftriaxone—GLUL—spinal cord—epilepsy syndrome	0.000471	0.0391	CbGeAlD
Ceftriaxone—GLUL—head—epilepsy syndrome	0.000419	0.0347	CbGeAlD
Ceftriaxone—GLUL—nervous system—epilepsy syndrome	0.000397	0.0329	CbGeAlD
Ceftriaxone—GLUL—central nervous system—epilepsy syndrome	0.000382	0.0317	CbGeAlD
Ceftriaxone—GLUL—cerebellum—epilepsy syndrome	0.000374	0.031	CbGeAlD
Ceftriaxone—SLC15A2—telencephalon—epilepsy syndrome	0.000348	0.0288	CbGeAlD
Ceftriaxone—GLUL—brain—epilepsy syndrome	0.000304	0.0252	CbGeAlD
Ceftriaxone—SLC22A6—brain—epilepsy syndrome	0.000301	0.025	CbGeAlD
Ceftriaxone—SLC15A2—medulla oblongata—epilepsy syndrome	0.000273	0.0227	CbGeAlD
Ceftriaxone—SLC15A2—midbrain—epilepsy syndrome	0.00025	0.0207	CbGeAlD
Ceftriaxone—SLC22A8—head—epilepsy syndrome	0.000249	0.0207	CbGeAlD
Ceftriaxone—SLC15A2—spinal cord—epilepsy syndrome	0.000244	0.0202	CbGeAlD
Ceftriaxone—SLC22A8—nervous system—epilepsy syndrome	0.000236	0.0196	CbGeAlD
Ceftriaxone—SLC22A8—central nervous system—epilepsy syndrome	0.000227	0.0189	CbGeAlD
Ceftriaxone—SLC15A2—head—epilepsy syndrome	0.000216	0.018	CbGeAlD
Ceftriaxone—SLC15A2—nervous system—epilepsy syndrome	0.000205	0.017	CbGeAlD
Ceftriaxone—SLC15A2—central nervous system—epilepsy syndrome	0.000198	0.0164	CbGeAlD
Ceftriaxone—SLC15A2—cerebellum—epilepsy syndrome	0.000193	0.016	CbGeAlD
Ceftriaxone—ALB—brain—epilepsy syndrome	0.000188	0.0156	CbGeAlD
Ceftriaxone—SLC22A8—brain—epilepsy syndrome	0.00018	0.015	CbGeAlD
Ceftriaxone—SLC15A2—brain—epilepsy syndrome	0.000157	0.013	CbGeAlD
Ceftriaxone—Cefotetan—ALB—epilepsy syndrome	0.00012	0.267	CrCbGaD
Ceftriaxone—Cefpiramide—ALB—epilepsy syndrome	0.000105	0.232	CrCbGaD
Ceftriaxone—Cefonicid—ALB—epilepsy syndrome	9.12e-05	0.202	CrCbGaD
Ceftriaxone—Dizziness—Midazolam—epilepsy syndrome	7.68e-05	0.000513	CcSEcCtD
Ceftriaxone—Abdominal pain—Clonazepam—epilepsy syndrome	7.66e-05	0.000512	CcSEcCtD
Ceftriaxone—Body temperature increased—Clonazepam—epilepsy syndrome	7.66e-05	0.000512	CcSEcCtD
Ceftriaxone—Dysgeusia—Pregabalin—epilepsy syndrome	7.66e-05	0.000511	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Topiramate—epilepsy syndrome	7.65e-05	0.000511	CcSEcCtD
Ceftriaxone—Urticaria—Phenytoin—epilepsy syndrome	7.65e-05	0.000511	CcSEcCtD
Ceftriaxone—Palpitations—Valproic Acid—epilepsy syndrome	7.64e-05	0.00051	CcSEcCtD
Ceftriaxone—Pruritus—Vigabatrin—epilepsy syndrome	7.63e-05	0.00051	CcSEcCtD
Ceftriaxone—Body temperature increased—Phenytoin—epilepsy syndrome	7.61e-05	0.000508	CcSEcCtD
Ceftriaxone—Urticaria—Oxcarbazepine—epilepsy syndrome	7.61e-05	0.000508	CcSEcCtD
Ceftriaxone—Pain—Lamotrigine—epilepsy syndrome	7.6e-05	0.000507	CcSEcCtD
Ceftriaxone—Renal failure—Topiramate—epilepsy syndrome	7.59e-05	0.000507	CcSEcCtD
Ceftriaxone—Nausea—Acetazolamide—epilepsy syndrome	7.59e-05	0.000507	CcSEcCtD
Ceftriaxone—Dizziness—Levetiracetam—epilepsy syndrome	7.58e-05	0.000506	CcSEcCtD
Ceftriaxone—Feeling abnormal—Carbamazepine—epilepsy syndrome	7.58e-05	0.000506	CcSEcCtD
Ceftriaxone—Abdominal pain—Oxcarbazepine—epilepsy syndrome	7.57e-05	0.000506	CcSEcCtD
Ceftriaxone—Body temperature increased—Oxcarbazepine—epilepsy syndrome	7.57e-05	0.000506	CcSEcCtD
Ceftriaxone—Diarrhoea—Fosphenytoin—epilepsy syndrome	7.57e-05	0.000506	CcSEcCtD
Ceftriaxone—Vomiting—Propofol—epilepsy syndrome	7.54e-05	0.000504	CcSEcCtD
Ceftriaxone—Stomatitis—Topiramate—epilepsy syndrome	7.53e-05	0.000503	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	7.52e-05	0.000502	CcSEcCtD
Ceftriaxone—Pruritus—Diazepam—epilepsy syndrome	7.51e-05	0.000502	CcSEcCtD
Ceftriaxone—Rash—Propofol—epilepsy syndrome	7.48e-05	0.0005	CcSEcCtD
Ceftriaxone—Dermatitis—Propofol—epilepsy syndrome	7.48e-05	0.000499	CcSEcCtD
Ceftriaxone—Headache—Propofol—epilepsy syndrome	7.43e-05	0.000496	CcSEcCtD
Ceftriaxone—Hypersensitivity—Zonisamide—epilepsy syndrome	7.41e-05	0.000495	CcSEcCtD
Ceftriaxone—Chills—Gabapentin—epilepsy syndrome	7.39e-05	0.000494	CcSEcCtD
Ceftriaxone—Vomiting—Midazolam—epilepsy syndrome	7.38e-05	0.000493	CcSEcCtD
Ceftriaxone—Diarrhoea—Vigabatrin—epilepsy syndrome	7.38e-05	0.000493	CcSEcCtD
Ceftriaxone—Haematuria—Topiramate—epilepsy syndrome	7.36e-05	0.000492	CcSEcCtD
Ceftriaxone—Feeling abnormal—Lamotrigine—epilepsy syndrome	7.32e-05	0.000489	CcSEcCtD
Ceftriaxone—Rash—Midazolam—epilepsy syndrome	7.32e-05	0.000489	CcSEcCtD
Ceftriaxone—Dizziness—Fosphenytoin—epilepsy syndrome	7.32e-05	0.000489	CcSEcCtD
Ceftriaxone—Dermatitis—Midazolam—epilepsy syndrome	7.31e-05	0.000488	CcSEcCtD
Ceftriaxone—Urticaria—Carbamazepine—epilepsy syndrome	7.3e-05	0.000488	CcSEcCtD
Ceftriaxone—Vomiting—Levetiracetam—epilepsy syndrome	7.29e-05	0.000487	CcSEcCtD
Ceftriaxone—Epistaxis—Topiramate—epilepsy syndrome	7.28e-05	0.000486	CcSEcCtD
Ceftriaxone—Discomfort—Valproic Acid—epilepsy syndrome	7.28e-05	0.000486	CcSEcCtD
Ceftriaxone—Headache—Midazolam—epilepsy syndrome	7.27e-05	0.000486	CcSEcCtD
Ceftriaxone—Pruritus—Felbamate—epilepsy syndrome	7.27e-05	0.000486	CcSEcCtD
Ceftriaxone—Body temperature increased—Carbamazepine—epilepsy syndrome	7.27e-05	0.000485	CcSEcCtD
Ceftriaxone—Abdominal pain—Carbamazepine—epilepsy syndrome	7.27e-05	0.000485	CcSEcCtD
Ceftriaxone—Diarrhoea—Diazepam—epilepsy syndrome	7.27e-05	0.000485	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	7.26e-05	0.000485	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Pregabalin—epilepsy syndrome	7.26e-05	0.000485	CcSEcCtD
Ceftriaxone—Rash—Levetiracetam—epilepsy syndrome	7.23e-05	0.000483	CcSEcCtD
Ceftriaxone—Anaemia—Pregabalin—epilepsy syndrome	7.23e-05	0.000483	CcSEcCtD
Ceftriaxone—Dermatitis—Levetiracetam—epilepsy syndrome	7.22e-05	0.000482	CcSEcCtD
Ceftriaxone—Agranulocytosis—Topiramate—epilepsy syndrome	7.2e-05	0.000481	CcSEcCtD
Ceftriaxone—Agitation—Pregabalin—epilepsy syndrome	7.19e-05	0.00048	CcSEcCtD
Ceftriaxone—Headache—Levetiracetam—epilepsy syndrome	7.18e-05	0.00048	CcSEcCtD
Ceftriaxone—Hypersensitivity—Clonazepam—epilepsy syndrome	7.14e-05	0.000477	CcSEcCtD
Ceftriaxone—Dizziness—Vigabatrin—epilepsy syndrome	7.13e-05	0.000476	CcSEcCtD
Ceftriaxone—Pruritus—Zonisamide—epilepsy syndrome	7.12e-05	0.000475	CcSEcCtD
Ceftriaxone—Hypersensitivity—Phenytoin—epilepsy syndrome	7.1e-05	0.000474	CcSEcCtD
Ceftriaxone—Flatulence—Gabapentin—epilepsy syndrome	7.07e-05	0.000472	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Valproic Acid—epilepsy syndrome	7.06e-05	0.000471	CcSEcCtD
Ceftriaxone—Oedema—Valproic Acid—epilepsy syndrome	7.06e-05	0.000471	CcSEcCtD
Ceftriaxone—Urticaria—Lamotrigine—epilepsy syndrome	7.06e-05	0.000471	CcSEcCtD
Ceftriaxone—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	7.06e-05	0.000471	CcSEcCtD
Ceftriaxone—Malaise—Pregabalin—epilepsy syndrome	7.05e-05	0.000471	CcSEcCtD
Ceftriaxone—Nausea—Propofol—epilepsy syndrome	7.05e-05	0.000471	CcSEcCtD
Ceftriaxone—Vomiting—Fosphenytoin—epilepsy syndrome	7.04e-05	0.00047	CcSEcCtD
Ceftriaxone—Diarrhoea—Felbamate—epilepsy syndrome	7.03e-05	0.00047	CcSEcCtD
Ceftriaxone—Abdominal pain—Lamotrigine—epilepsy syndrome	7.02e-05	0.000469	CcSEcCtD
Ceftriaxone—Body temperature increased—Lamotrigine—epilepsy syndrome	7.02e-05	0.000469	CcSEcCtD
Ceftriaxone—Dysgeusia—Gabapentin—epilepsy syndrome	7.02e-05	0.000469	CcSEcCtD
Ceftriaxone—Dizziness—Diazepam—epilepsy syndrome	7.02e-05	0.000469	CcSEcCtD
Ceftriaxone—Infection—Valproic Acid—epilepsy syndrome	7.01e-05	0.000468	CcSEcCtD
Ceftriaxone—Leukopenia—Pregabalin—epilepsy syndrome	7e-05	0.000467	CcSEcCtD
Ceftriaxone—Rash—Fosphenytoin—epilepsy syndrome	6.98e-05	0.000466	CcSEcCtD
Ceftriaxone—Dermatitis—Fosphenytoin—epilepsy syndrome	6.97e-05	0.000465	CcSEcCtD
Ceftriaxone—Haemoglobin—Topiramate—epilepsy syndrome	6.97e-05	0.000465	CcSEcCtD
Ceftriaxone—Headache—Fosphenytoin—epilepsy syndrome	6.93e-05	0.000463	CcSEcCtD
Ceftriaxone—Haemorrhage—Topiramate—epilepsy syndrome	6.93e-05	0.000463	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Valproic Acid—epilepsy syndrome	6.91e-05	0.000462	CcSEcCtD
Ceftriaxone—Palpitations—Pregabalin—epilepsy syndrome	6.91e-05	0.000461	CcSEcCtD
Ceftriaxone—Nausea—Midazolam—epilepsy syndrome	6.9e-05	0.000461	CcSEcCtD
Ceftriaxone—Diarrhoea—Zonisamide—epilepsy syndrome	6.88e-05	0.00046	CcSEcCtD
Ceftriaxone—Pruritus—Clonazepam—epilepsy syndrome	6.86e-05	0.000458	CcSEcCtD
Ceftriaxone—Vomiting—Vigabatrin—epilepsy syndrome	6.86e-05	0.000458	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Valproic Acid—epilepsy syndrome	6.82e-05	0.000456	CcSEcCtD
Ceftriaxone—Pruritus—Phenytoin—epilepsy syndrome	6.81e-05	0.000455	CcSEcCtD
Ceftriaxone—Nausea—Levetiracetam—epilepsy syndrome	6.81e-05	0.000455	CcSEcCtD
Ceftriaxone—Rash—Vigabatrin—epilepsy syndrome	6.8e-05	0.000454	CcSEcCtD
Ceftriaxone—Dizziness—Felbamate—epilepsy syndrome	6.8e-05	0.000454	CcSEcCtD
Ceftriaxone—Dermatitis—Vigabatrin—epilepsy syndrome	6.79e-05	0.000454	CcSEcCtD
Ceftriaxone—Pruritus—Oxcarbazepine—epilepsy syndrome	6.78e-05	0.000453	CcSEcCtD
Ceftriaxone—Convulsion—Pregabalin—epilepsy syndrome	6.78e-05	0.000452	CcSEcCtD
Ceftriaxone—Hypersensitivity—Carbamazepine—epilepsy syndrome	6.77e-05	0.000452	CcSEcCtD
Ceftriaxone—Headache—Vigabatrin—epilepsy syndrome	6.76e-05	0.000451	CcSEcCtD
Ceftriaxone—Vomiting—Diazepam—epilepsy syndrome	6.75e-05	0.000451	CcSEcCtD
Ceftriaxone—Rash—Diazepam—epilepsy syndrome	6.7e-05	0.000447	CcSEcCtD
Ceftriaxone—Dermatitis—Diazepam—epilepsy syndrome	6.69e-05	0.000447	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Gabapentin—epilepsy syndrome	6.65e-05	0.000444	CcSEcCtD
Ceftriaxone—Dizziness—Zonisamide—epilepsy syndrome	6.65e-05	0.000444	CcSEcCtD
Ceftriaxone—Headache—Diazepam—epilepsy syndrome	6.65e-05	0.000444	CcSEcCtD
Ceftriaxone—Diarrhoea—Clonazepam—epilepsy syndrome	6.63e-05	0.000443	CcSEcCtD
Ceftriaxone—Anaemia—Gabapentin—epilepsy syndrome	6.63e-05	0.000443	CcSEcCtD
Ceftriaxone—Agitation—Gabapentin—epilepsy syndrome	6.59e-05	0.00044	CcSEcCtD
Ceftriaxone—Diarrhoea—Phenytoin—epilepsy syndrome	6.59e-05	0.00044	CcSEcCtD
Ceftriaxone—Discomfort—Pregabalin—epilepsy syndrome	6.58e-05	0.000439	CcSEcCtD
Ceftriaxone—Nausea—Fosphenytoin—epilepsy syndrome	6.57e-05	0.000439	CcSEcCtD
Ceftriaxone—Diarrhoea—Oxcarbazepine—epilepsy syndrome	6.55e-05	0.000438	CcSEcCtD
Ceftriaxone—Erythema multiforme—Topiramate—epilepsy syndrome	6.55e-05	0.000438	CcSEcCtD
Ceftriaxone—Hypersensitivity—Lamotrigine—epilepsy syndrome	6.55e-05	0.000437	CcSEcCtD
Ceftriaxone—Vomiting—Felbamate—epilepsy syndrome	6.53e-05	0.000436	CcSEcCtD
Ceftriaxone—Pruritus—Carbamazepine—epilepsy syndrome	6.5e-05	0.000434	CcSEcCtD
Ceftriaxone—Rash—Felbamate—epilepsy syndrome	6.48e-05	0.000433	CcSEcCtD
Ceftriaxone—Dermatitis—Felbamate—epilepsy syndrome	6.47e-05	0.000432	CcSEcCtD
Ceftriaxone—Malaise—Gabapentin—epilepsy syndrome	6.47e-05	0.000432	CcSEcCtD
Ceftriaxone—Headache—Felbamate—epilepsy syndrome	6.44e-05	0.00043	CcSEcCtD
Ceftriaxone—Flushing—Topiramate—epilepsy syndrome	6.43e-05	0.00043	CcSEcCtD
Ceftriaxone—Leukopenia—Gabapentin—epilepsy syndrome	6.42e-05	0.000429	CcSEcCtD
Ceftriaxone—Dizziness—Clonazepam—epilepsy syndrome	6.41e-05	0.000428	CcSEcCtD
Ceftriaxone—Nausea—Vigabatrin—epilepsy syndrome	6.41e-05	0.000428	CcSEcCtD
Ceftriaxone—Vomiting—Zonisamide—epilepsy syndrome	6.4e-05	0.000427	CcSEcCtD
Ceftriaxone—Oedema—Pregabalin—epilepsy syndrome	6.38e-05	0.000426	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Pregabalin—epilepsy syndrome	6.38e-05	0.000426	CcSEcCtD
Ceftriaxone—Dizziness—Phenytoin—epilepsy syndrome	6.37e-05	0.000425	CcSEcCtD
Ceftriaxone—Rash—Zonisamide—epilepsy syndrome	6.34e-05	0.000424	CcSEcCtD
Ceftriaxone—Infection—Pregabalin—epilepsy syndrome	6.34e-05	0.000423	CcSEcCtD
Ceftriaxone—Paraesthesia—Valproic Acid—epilepsy syndrome	6.34e-05	0.000423	CcSEcCtD
Ceftriaxone—Palpitations—Gabapentin—epilepsy syndrome	6.34e-05	0.000423	CcSEcCtD
Ceftriaxone—Dermatitis—Zonisamide—epilepsy syndrome	6.34e-05	0.000423	CcSEcCtD
Ceftriaxone—Dizziness—Oxcarbazepine—epilepsy syndrome	6.33e-05	0.000423	CcSEcCtD
Ceftriaxone—Nausea—Diazepam—epilepsy syndrome	6.31e-05	0.000421	CcSEcCtD
Ceftriaxone—Headache—Zonisamide—epilepsy syndrome	6.3e-05	0.000421	CcSEcCtD
Ceftriaxone—Diarrhoea—Carbamazepine—epilepsy syndrome	6.29e-05	0.00042	CcSEcCtD
Ceftriaxone—Pruritus—Lamotrigine—epilepsy syndrome	6.29e-05	0.00042	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Pregabalin—epilepsy syndrome	6.25e-05	0.000417	CcSEcCtD
Ceftriaxone—Chills—Topiramate—epilepsy syndrome	6.22e-05	0.000415	CcSEcCtD
Ceftriaxone—Dyspepsia—Valproic Acid—epilepsy syndrome	6.21e-05	0.000415	CcSEcCtD
Ceftriaxone—Convulsion—Gabapentin—epilepsy syndrome	6.21e-05	0.000415	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Pregabalin—epilepsy syndrome	6.17e-05	0.000412	CcSEcCtD
Ceftriaxone—Vomiting—Clonazepam—epilepsy syndrome	6.16e-05	0.000412	CcSEcCtD
Ceftriaxone—Vomiting—Phenytoin—epilepsy syndrome	6.12e-05	0.000409	CcSEcCtD
Ceftriaxone—Rash—Clonazepam—epilepsy syndrome	6.11e-05	0.000408	CcSEcCtD
Ceftriaxone—Dermatitis—Clonazepam—epilepsy syndrome	6.11e-05	0.000408	CcSEcCtD
Ceftriaxone—Nausea—Felbamate—epilepsy syndrome	6.1e-05	0.000408	CcSEcCtD
Ceftriaxone—Vomiting—Oxcarbazepine—epilepsy syndrome	6.09e-05	0.000407	CcSEcCtD
Ceftriaxone—Dizziness—Carbamazepine—epilepsy syndrome	6.08e-05	0.000406	CcSEcCtD
Ceftriaxone—Diarrhoea—Lamotrigine—epilepsy syndrome	6.08e-05	0.000406	CcSEcCtD
Ceftriaxone—Headache—Clonazepam—epilepsy syndrome	6.07e-05	0.000406	CcSEcCtD
Ceftriaxone—Rash—Phenytoin—epilepsy syndrome	6.07e-05	0.000405	CcSEcCtD
Ceftriaxone—Dermatitis—Phenytoin—epilepsy syndrome	6.07e-05	0.000405	CcSEcCtD
Ceftriaxone—Rash—Oxcarbazepine—epilepsy syndrome	6.04e-05	0.000403	CcSEcCtD
Ceftriaxone—Pain—Valproic Acid—epilepsy syndrome	6.04e-05	0.000403	CcSEcCtD
Ceftriaxone—Dermatitis—Oxcarbazepine—epilepsy syndrome	6.03e-05	0.000403	CcSEcCtD
Ceftriaxone—Headache—Phenytoin—epilepsy syndrome	6.03e-05	0.000403	CcSEcCtD
Ceftriaxone—Discomfort—Gabapentin—epilepsy syndrome	6.03e-05	0.000403	CcSEcCtD
Ceftriaxone—Headache—Oxcarbazepine—epilepsy syndrome	6e-05	0.000401	CcSEcCtD
Ceftriaxone—Nausea—Zonisamide—epilepsy syndrome	5.98e-05	0.000399	CcSEcCtD
Ceftriaxone—Flatulence—Topiramate—epilepsy syndrome	5.94e-05	0.000397	CcSEcCtD
Ceftriaxone—Dysgeusia—Topiramate—epilepsy syndrome	5.91e-05	0.000395	CcSEcCtD
Ceftriaxone—Dizziness—Lamotrigine—epilepsy syndrome	5.87e-05	0.000392	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Gabapentin—epilepsy syndrome	5.85e-05	0.000391	CcSEcCtD
Ceftriaxone—Oedema—Gabapentin—epilepsy syndrome	5.85e-05	0.000391	CcSEcCtD
Ceftriaxone—Vomiting—Carbamazepine—epilepsy syndrome	5.84e-05	0.00039	CcSEcCtD
Ceftriaxone—Feeling abnormal—Valproic Acid—epilepsy syndrome	5.82e-05	0.000388	CcSEcCtD
Ceftriaxone—Infection—Gabapentin—epilepsy syndrome	5.81e-05	0.000388	CcSEcCtD
Ceftriaxone—Rash—Carbamazepine—epilepsy syndrome	5.8e-05	0.000387	CcSEcCtD
Ceftriaxone—Dermatitis—Carbamazepine—epilepsy syndrome	5.79e-05	0.000387	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	5.77e-05	0.000386	CcSEcCtD
Ceftriaxone—Nausea—Clonazepam—epilepsy syndrome	5.76e-05	0.000385	CcSEcCtD
Ceftriaxone—Headache—Carbamazepine—epilepsy syndrome	5.76e-05	0.000385	CcSEcCtD
Ceftriaxone—Paraesthesia—Pregabalin—epilepsy syndrome	5.73e-05	0.000383	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Gabapentin—epilepsy syndrome	5.73e-05	0.000383	CcSEcCtD
Ceftriaxone—Nausea—Phenytoin—epilepsy syndrome	5.72e-05	0.000382	CcSEcCtD
Ceftriaxone—Nausea—Oxcarbazepine—epilepsy syndrome	5.69e-05	0.00038	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Gabapentin—epilepsy syndrome	5.66e-05	0.000378	CcSEcCtD
Ceftriaxone—Vomiting—Lamotrigine—epilepsy syndrome	5.65e-05	0.000377	CcSEcCtD
Ceftriaxone—Urticaria—Valproic Acid—epilepsy syndrome	5.61e-05	0.000375	CcSEcCtD
Ceftriaxone—Rash—Lamotrigine—epilepsy syndrome	5.6e-05	0.000374	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Topiramate—epilepsy syndrome	5.6e-05	0.000374	CcSEcCtD
Ceftriaxone—Dermatitis—Lamotrigine—epilepsy syndrome	5.6e-05	0.000374	CcSEcCtD
Ceftriaxone—Body temperature increased—Valproic Acid—epilepsy syndrome	5.58e-05	0.000373	CcSEcCtD
Ceftriaxone—Abdominal pain—Valproic Acid—epilepsy syndrome	5.58e-05	0.000373	CcSEcCtD
Ceftriaxone—Anaemia—Topiramate—epilepsy syndrome	5.58e-05	0.000372	CcSEcCtD
Ceftriaxone—Headache—Lamotrigine—epilepsy syndrome	5.57e-05	0.000372	CcSEcCtD
Ceftriaxone—Agitation—Topiramate—epilepsy syndrome	5.54e-05	0.00037	CcSEcCtD
Ceftriaxone—Nausea—Carbamazepine—epilepsy syndrome	5.46e-05	0.000365	CcSEcCtD
Ceftriaxone—Pain—Pregabalin—epilepsy syndrome	5.46e-05	0.000364	CcSEcCtD
Ceftriaxone—Malaise—Topiramate—epilepsy syndrome	5.44e-05	0.000363	CcSEcCtD
Ceftriaxone—Leukopenia—Topiramate—epilepsy syndrome	5.4e-05	0.000361	CcSEcCtD
Ceftriaxone—Cefoperazone—ALB—epilepsy syndrome	5.37e-05	0.119	CrCbGaD
Ceftriaxone—Palpitations—Topiramate—epilepsy syndrome	5.33e-05	0.000356	CcSEcCtD
Ceftriaxone—Nausea—Lamotrigine—epilepsy syndrome	5.28e-05	0.000352	CcSEcCtD
Ceftriaxone—Feeling abnormal—Pregabalin—epilepsy syndrome	5.26e-05	0.000351	CcSEcCtD
Ceftriaxone—Paraesthesia—Gabapentin—epilepsy syndrome	5.26e-05	0.000351	CcSEcCtD
Ceftriaxone—Convulsion—Topiramate—epilepsy syndrome	5.23e-05	0.000349	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Pregabalin—epilepsy syndrome	5.22e-05	0.000349	CcSEcCtD
Ceftriaxone—Hypersensitivity—Valproic Acid—epilepsy syndrome	5.2e-05	0.000347	CcSEcCtD
Ceftriaxone—Dyspepsia—Gabapentin—epilepsy syndrome	5.15e-05	0.000344	CcSEcCtD
Ceftriaxone—Discomfort—Topiramate—epilepsy syndrome	5.07e-05	0.000339	CcSEcCtD
Ceftriaxone—Urticaria—Pregabalin—epilepsy syndrome	5.07e-05	0.000339	CcSEcCtD
Ceftriaxone—Body temperature increased—Pregabalin—epilepsy syndrome	5.05e-05	0.000337	CcSEcCtD
Ceftriaxone—Abdominal pain—Pregabalin—epilepsy syndrome	5.05e-05	0.000337	CcSEcCtD
Ceftriaxone—Pain—Gabapentin—epilepsy syndrome	5e-05	0.000334	CcSEcCtD
Ceftriaxone—Pruritus—Valproic Acid—epilepsy syndrome	4.99e-05	0.000334	CcSEcCtD
Ceftriaxone—Oedema—Topiramate—epilepsy syndrome	4.92e-05	0.000329	CcSEcCtD
Ceftriaxone—Infection—Topiramate—epilepsy syndrome	4.89e-05	0.000327	CcSEcCtD
Ceftriaxone—Diarrhoea—Valproic Acid—epilepsy syndrome	4.83e-05	0.000323	CcSEcCtD
Ceftriaxone—Feeling abnormal—Gabapentin—epilepsy syndrome	4.82e-05	0.000322	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Topiramate—epilepsy syndrome	4.82e-05	0.000322	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Gabapentin—epilepsy syndrome	4.79e-05	0.00032	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Topiramate—epilepsy syndrome	4.76e-05	0.000318	CcSEcCtD
Ceftriaxone—Hypersensitivity—Pregabalin—epilepsy syndrome	4.7e-05	0.000314	CcSEcCtD
Ceftriaxone—Dizziness—Valproic Acid—epilepsy syndrome	4.67e-05	0.000312	CcSEcCtD
Ceftriaxone—Urticaria—Gabapentin—epilepsy syndrome	4.65e-05	0.00031	CcSEcCtD
Ceftriaxone—Abdominal pain—Gabapentin—epilepsy syndrome	4.63e-05	0.000309	CcSEcCtD
Ceftriaxone—Body temperature increased—Gabapentin—epilepsy syndrome	4.63e-05	0.000309	CcSEcCtD
Ceftriaxone—Pruritus—Pregabalin—epilepsy syndrome	4.52e-05	0.000302	CcSEcCtD
Ceftriaxone—Vomiting—Valproic Acid—epilepsy syndrome	4.49e-05	0.0003	CcSEcCtD
Ceftriaxone—Rash—Valproic Acid—epilepsy syndrome	4.45e-05	0.000297	CcSEcCtD
Ceftriaxone—Dermatitis—Valproic Acid—epilepsy syndrome	4.45e-05	0.000297	CcSEcCtD
Ceftriaxone—Headache—Valproic Acid—epilepsy syndrome	4.42e-05	0.000295	CcSEcCtD
Ceftriaxone—Paraesthesia—Topiramate—epilepsy syndrome	4.42e-05	0.000295	CcSEcCtD
Ceftriaxone—Cefazolin—ALB—epilepsy syndrome	4.41e-05	0.098	CrCbGaD
Ceftriaxone—Diarrhoea—Pregabalin—epilepsy syndrome	4.37e-05	0.000292	CcSEcCtD
Ceftriaxone—Dyspepsia—Topiramate—epilepsy syndrome	4.33e-05	0.000289	CcSEcCtD
Ceftriaxone—Hypersensitivity—Gabapentin—epilepsy syndrome	4.31e-05	0.000288	CcSEcCtD
Ceftriaxone—Dizziness—Pregabalin—epilepsy syndrome	4.22e-05	0.000282	CcSEcCtD
Ceftriaxone—Pain—Topiramate—epilepsy syndrome	4.21e-05	0.000281	CcSEcCtD
Ceftriaxone—Nausea—Valproic Acid—epilepsy syndrome	4.19e-05	0.00028	CcSEcCtD
Ceftriaxone—Pruritus—Gabapentin—epilepsy syndrome	4.14e-05	0.000277	CcSEcCtD
Ceftriaxone—Vomiting—Pregabalin—epilepsy syndrome	4.06e-05	0.000271	CcSEcCtD
Ceftriaxone—Feeling abnormal—Topiramate—epilepsy syndrome	4.06e-05	0.000271	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Topiramate—epilepsy syndrome	4.03e-05	0.000269	CcSEcCtD
Ceftriaxone—Rash—Pregabalin—epilepsy syndrome	4.02e-05	0.000269	CcSEcCtD
Ceftriaxone—Dermatitis—Pregabalin—epilepsy syndrome	4.02e-05	0.000268	CcSEcCtD
Ceftriaxone—Diarrhoea—Gabapentin—epilepsy syndrome	4e-05	0.000267	CcSEcCtD
Ceftriaxone—Headache—Pregabalin—epilepsy syndrome	4e-05	0.000267	CcSEcCtD
Ceftriaxone—Urticaria—Topiramate—epilepsy syndrome	3.91e-05	0.000261	CcSEcCtD
Ceftriaxone—Abdominal pain—Topiramate—epilepsy syndrome	3.89e-05	0.00026	CcSEcCtD
Ceftriaxone—Body temperature increased—Topiramate—epilepsy syndrome	3.89e-05	0.00026	CcSEcCtD
Ceftriaxone—Dizziness—Gabapentin—epilepsy syndrome	3.87e-05	0.000258	CcSEcCtD
Ceftriaxone—Nausea—Pregabalin—epilepsy syndrome	3.79e-05	0.000253	CcSEcCtD
Ceftriaxone—Vomiting—Gabapentin—epilepsy syndrome	3.72e-05	0.000248	CcSEcCtD
Ceftriaxone—Rash—Gabapentin—epilepsy syndrome	3.69e-05	0.000246	CcSEcCtD
Ceftriaxone—Dermatitis—Gabapentin—epilepsy syndrome	3.69e-05	0.000246	CcSEcCtD
Ceftriaxone—Headache—Gabapentin—epilepsy syndrome	3.67e-05	0.000245	CcSEcCtD
Ceftriaxone—Cefalotin—ALB—epilepsy syndrome	3.67e-05	0.0814	CrCbGaD
Ceftriaxone—Hypersensitivity—Topiramate—epilepsy syndrome	3.63e-05	0.000242	CcSEcCtD
Ceftriaxone—ALB—Vitamin B12 Metabolism—CCL2—epilepsy syndrome	3.52e-05	0.000442	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	3.51e-05	0.00044	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—CAT—epilepsy syndrome	3.48e-05	0.000438	CbGpPWpGaD
Ceftriaxone—Pruritus—Topiramate—epilepsy syndrome	3.48e-05	0.000233	CcSEcCtD
Ceftriaxone—ALB—Folate Metabolism—CRP—epilepsy syndrome	3.48e-05	0.000437	CbGpPWpGaD
Ceftriaxone—Nausea—Gabapentin—epilepsy syndrome	3.48e-05	0.000232	CcSEcCtD
Ceftriaxone—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	3.47e-05	0.000436	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	3.46e-05	0.000435	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	3.46e-05	0.000435	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	3.46e-05	0.000435	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	3.46e-05	0.000435	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	3.43e-05	0.00043	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	3.43e-05	0.00043	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	3.43e-05	0.00043	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	3.42e-05	0.000429	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	3.4e-05	0.000426	CbGpPWpGaD
Ceftriaxone—SLC22A8—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	3.39e-05	0.000426	CbGpPWpGaD
Ceftriaxone—Diarrhoea—Topiramate—epilepsy syndrome	3.37e-05	0.000225	CcSEcCtD
Ceftriaxone—GLUL—Metabolism—ABCG2—epilepsy syndrome	3.3e-05	0.000414	CbGpPWpGaD
Ceftriaxone—ALB—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	3.29e-05	0.000414	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	3.29e-05	0.000413	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	3.28e-05	0.000412	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	3.28e-05	0.000412	CbGpPWpGaD
Ceftriaxone—Dizziness—Topiramate—epilepsy syndrome	3.26e-05	0.000217	CcSEcCtD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	3.24e-05	0.000407	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	3.22e-05	0.000404	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CYP2C19—epilepsy syndrome	3.21e-05	0.000404	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CYP11A1—epilepsy syndrome	3.19e-05	0.000401	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	3.16e-05	0.000396	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—GPX1—epilepsy syndrome	3.15e-05	0.000396	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	3.14e-05	0.000395	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	3.13e-05	0.000394	CbGpPWpGaD
Ceftriaxone—Vomiting—Topiramate—epilepsy syndrome	3.13e-05	0.000209	CcSEcCtD
Ceftriaxone—Rash—Topiramate—epilepsy syndrome	3.1e-05	0.000207	CcSEcCtD
Ceftriaxone—Dermatitis—Topiramate—epilepsy syndrome	3.1e-05	0.000207	CcSEcCtD
Ceftriaxone—Headache—Topiramate—epilepsy syndrome	3.08e-05	0.000206	CcSEcCtD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	3.07e-05	0.000386	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	3.03e-05	0.00038	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	3.01e-05	0.000378	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SLC8A2—epilepsy syndrome	3e-05	0.000377	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—RELA—epilepsy syndrome	2.95e-05	0.000371	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	2.94e-05	0.00037	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	2.93e-05	0.000368	CbGpPWpGaD
Ceftriaxone—Nausea—Topiramate—epilepsy syndrome	2.92e-05	0.000195	CcSEcCtD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	2.92e-05	0.000367	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.91e-05	0.000365	CbGpPWpGaD
Ceftriaxone—ALB—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	2.9e-05	0.000364	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CYP2D6—epilepsy syndrome	2.88e-05	0.000362	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—CCL2—epilepsy syndrome	2.86e-05	0.00036	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SLC8A3—epilepsy syndrome	2.86e-05	0.000359	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	2.83e-05	0.000356	CbGpPWpGaD
Ceftriaxone—SLC22A6—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	2.83e-05	0.000355	CbGpPWpGaD
Ceftriaxone—ALB—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	2.8e-05	0.000352	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PPIA—epilepsy syndrome	2.77e-05	0.000348	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.77e-05	0.000348	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—CRP—epilepsy syndrome	2.77e-05	0.000347	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ADRA2A—epilepsy syndrome	2.74e-05	0.000345	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—COX3—epilepsy syndrome	2.74e-05	0.000344	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	2.74e-05	0.000344	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	2.74e-05	0.000344	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—BCHE—epilepsy syndrome	2.73e-05	0.000343	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	2.73e-05	0.000343	CbGpPWpGaD
Ceftriaxone—SLC22A11—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	2.69e-05	0.000338	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.68e-05	0.000337	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	2.67e-05	0.000336	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—IL1B—epilepsy syndrome	2.67e-05	0.000335	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—PRKCB—epilepsy syndrome	2.62e-05	0.00033	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	2.62e-05	0.00033	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—SLC2A1—epilepsy syndrome	2.61e-05	0.000327	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	2.61e-05	0.000327	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	2.6e-05	0.000326	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	2.6e-05	0.000326	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	2.6e-05	0.000326	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PLCB1—epilepsy syndrome	2.58e-05	0.000324	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—TH—epilepsy syndrome	2.57e-05	0.000323	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.56e-05	0.000322	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	2.5e-05	0.000314	CbGpPWpGaD
Ceftriaxone—ALB—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	2.5e-05	0.000313	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.49e-05	0.000313	CbGpPWpGaD
Ceftriaxone—SLC15A2—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	2.49e-05	0.000313	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	2.48e-05	0.000311	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	2.48e-05	0.000311	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	2.44e-05	0.000306	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	2.4e-05	0.000302	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—RELA—epilepsy syndrome	2.4e-05	0.000302	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.38e-05	0.000298	CbGpPWpGaD
Ceftriaxone—SLC15A1—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	2.31e-05	0.00029	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.28e-05	0.000286	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—CCL2—epilepsy syndrome	2.28e-05	0.000286	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.26e-05	0.000284	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	2.23e-05	0.00028	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.22e-05	0.000278	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.19e-05	0.000275	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	2.18e-05	0.000274	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	2.17e-05	0.000273	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—IL1B—epilepsy syndrome	2.17e-05	0.000273	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—ADRA2A—epilepsy syndrome	2.16e-05	0.000272	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—HMOX1—epilepsy syndrome	2.14e-05	0.000269	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CA13—epilepsy syndrome	2.12e-05	0.000266	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CAT—epilepsy syndrome	2.12e-05	0.000266	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.11e-05	0.000265	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.11e-05	0.000264	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.09e-05	0.000262	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ABCB1—epilepsy syndrome	2.06e-05	0.000258	CbGpPWpGaD
Ceftriaxone—SLC22A8—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	2.05e-05	0.000258	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.02e-05	0.000254	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—APOD—epilepsy syndrome	2.02e-05	0.000254	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	1.97e-05	0.000247	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	1.97e-05	0.000247	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.95e-05	0.000245	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—TNF—epilepsy syndrome	1.94e-05	0.000243	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.94e-05	0.000243	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—TEK—epilepsy syndrome	1.93e-05	0.000243	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—GPX1—epilepsy syndrome	1.91e-05	0.00024	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—RELA—epilepsy syndrome	1.91e-05	0.00024	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—AKT3—epilepsy syndrome	1.9e-05	0.000238	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	1.88e-05	0.000236	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.88e-05	0.000236	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—PTGS2—epilepsy syndrome	1.85e-05	0.000233	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.85e-05	0.000232	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—FLNA—epilepsy syndrome	1.82e-05	0.000228	CbGpPWpGaD
Ceftriaxone—ALB—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	1.8e-05	0.000227	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	1.8e-05	0.000226	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	1.8e-05	0.000226	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	1.8e-05	0.000226	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	1.8e-05	0.000226	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.76e-05	0.000222	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.74e-05	0.000218	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—CDC42—epilepsy syndrome	1.73e-05	0.000217	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—IL1B—epilepsy syndrome	1.73e-05	0.000217	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—KCNMA1—epilepsy syndrome	1.72e-05	0.000216	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.72e-05	0.000216	CbGpPWpGaD
Ceftriaxone—SLC22A6—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	1.71e-05	0.000215	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	1.7e-05	0.000214	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SLC8A1—epilepsy syndrome	1.7e-05	0.000214	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—AGT—epilepsy syndrome	1.68e-05	0.000211	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	1.67e-05	0.00021	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.67e-05	0.00021	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—APOE—epilepsy syndrome	1.64e-05	0.000206	CbGpPWpGaD
Ceftriaxone—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—epilepsy syndrome	1.62e-05	0.000204	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CERS1—epilepsy syndrome	1.61e-05	0.000202	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PDXK—epilepsy syndrome	1.61e-05	0.000202	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—L2HGDH—epilepsy syndrome	1.61e-05	0.000202	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GLUD1—epilepsy syndrome	1.61e-05	0.000202	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ADK—epilepsy syndrome	1.61e-05	0.000202	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—FAR1—epilepsy syndrome	1.61e-05	0.000202	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	1.6e-05	0.0002	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—VEGFA—epilepsy syndrome	1.58e-05	0.000198	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—TNF—epilepsy syndrome	1.58e-05	0.000198	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	1.57e-05	0.000198	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—FYN—epilepsy syndrome	1.54e-05	0.000193	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	1.53e-05	0.000192	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—epilepsy syndrome	1.5e-05	0.000189	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—YWHAZ—epilepsy syndrome	1.48e-05	0.000186	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	1.47e-05	0.000185	CbGpPWpGaD
Ceftriaxone—ALB—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	1.47e-05	0.000185	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—EPM2A—epilepsy syndrome	1.47e-05	0.000184	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NHLRC1—epilepsy syndrome	1.47e-05	0.000184	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GAMT—epilepsy syndrome	1.47e-05	0.000184	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PNPO—epilepsy syndrome	1.47e-05	0.000184	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.45e-05	0.000182	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.44e-05	0.000181	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PPIA—epilepsy syndrome	1.43e-05	0.00018	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	1.42e-05	0.000179	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	1.42e-05	0.000179	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—POMC—epilepsy syndrome	1.41e-05	0.000177	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.39e-05	0.000175	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.37e-05	0.000172	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CA4—epilepsy syndrome	1.36e-05	0.000171	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—QDPR—epilepsy syndrome	1.36e-05	0.000171	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	1.36e-05	0.000171	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—ATP2A2—epilepsy syndrome	1.31e-05	0.000164	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ALB—epilepsy syndrome	1.29e-05	0.000162	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—COX3—epilepsy syndrome	1.28e-05	0.000161	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	1.27e-05	0.000159	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—ITGA2—epilepsy syndrome	1.27e-05	0.000159	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.26e-05	0.000159	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—TNF—epilepsy syndrome	1.25e-05	0.000157	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PRKCB—epilepsy syndrome	1.22e-05	0.000153	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PFKL—epilepsy syndrome	1.22e-05	0.000153	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—KCNB1—epilepsy syndrome	1.22e-05	0.000153	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SLCO1A2—epilepsy syndrome	1.22e-05	0.000153	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CACNA2D2—epilepsy syndrome	1.22e-05	0.000153	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SLC6A8—epilepsy syndrome	1.22e-05	0.000153	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.19e-05	0.000149	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.18e-05	0.000148	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.17e-05	0.000147	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	1.16e-05	0.000146	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.13e-05	0.000142	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PTGS2—epilepsy syndrome	1.13e-05	0.000141	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—ADRA2A—epilepsy syndrome	1.12e-05	0.00014	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—UPB1—epilepsy syndrome	1.11e-05	0.00014	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NEU1—epilepsy syndrome	1.11e-05	0.00014	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ATIC—epilepsy syndrome	1.11e-05	0.00014	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PLAT—epilepsy syndrome	1.11e-05	0.000139	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HSD17B4—epilepsy syndrome	1.07e-05	0.000134	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—NOS1—epilepsy syndrome	1.04e-05	0.000131	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.04e-05	0.000131	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GBE1—epilepsy syndrome	1.03e-05	0.00013	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PPP1R3C—epilepsy syndrome	1.03e-05	0.00013	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.01e-05	0.000127	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—AKT3—epilepsy syndrome	9.78e-06	0.000123	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ASAH1—epilepsy syndrome	9.72e-06	0.000122	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PLAUR—epilepsy syndrome	9.66e-06	0.000121	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	9.61e-06	0.000121	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—STXBP1—epilepsy syndrome	9.46e-06	0.000119	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NT5E—epilepsy syndrome	9.22e-06	0.000116	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ALAD—epilepsy syndrome	9.22e-06	0.000116	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	9.17e-06	0.000115	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—CDC42—epilepsy syndrome	8.92e-06	0.000112	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CACNA1A—epilepsy syndrome	8.79e-06	0.00011	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ALDH7A1—epilepsy syndrome	8.79e-06	0.00011	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—ALB—epilepsy syndrome	8.71e-06	0.000109	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ST3GAL3—epilepsy syndrome	8.61e-06	0.000108	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ADSL—epilepsy syndrome	8.43e-06	0.000106	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GLUL—epilepsy syndrome	8.27e-06	0.000104	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CACNA1D—epilepsy syndrome	8.12e-06	0.000102	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—FYN—epilepsy syndrome	7.94e-06	9.97e-05	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—YWHAZ—epilepsy syndrome	7.63e-06	9.59e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—TXNRD1—epilepsy syndrome	7.59e-06	9.53e-05	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	7.54e-06	9.47e-05	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—AVP—epilepsy syndrome	7.48e-06	9.39e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—AQP1—epilepsy syndrome	7.37e-06	9.25e-05	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	7.24e-06	9.09e-05	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	7.18e-06	9.02e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	7.08e-06	8.89e-05	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	6.99e-06	8.78e-05	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PLAU—epilepsy syndrome	6.78e-06	8.51e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CHRM3—epilepsy syndrome	6.67e-06	8.37e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—KCNJ11—epilepsy syndrome	6.67e-06	8.37e-05	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PRKCB—epilepsy syndrome	6.3e-06	7.91e-05	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—NOS2—epilepsy syndrome	6.22e-06	7.82e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	6.21e-06	7.79e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6.08e-06	7.64e-05	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—AKT1—epilepsy syndrome	5.66e-06	7.11e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ABCG2—epilepsy syndrome	5.43e-06	6.82e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP2C19—epilepsy syndrome	5.29e-06	6.65e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP11A1—epilepsy syndrome	5.26e-06	6.61e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.22e-06	6.56e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP2D6—epilepsy syndrome	4.75e-06	5.96e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ADRA2A—epilepsy syndrome	4.52e-06	5.68e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—BCHE—epilepsy syndrome	4.5e-06	5.65e-05	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	4.46e-06	5.6e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SLC2A1—epilepsy syndrome	4.29e-06	5.39e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PLCB1—epilepsy syndrome	4.25e-06	5.33e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—TH—epilepsy syndrome	4.23e-06	5.32e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.17e-06	5.23e-05	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SRC—epilepsy syndrome	3.7e-06	4.65e-05	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—VEGFA—epilepsy syndrome	3.61e-06	4.53e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HMOX1—epilepsy syndrome	3.53e-06	4.44e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CAT—epilepsy syndrome	3.49e-06	4.38e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ABCB1—epilepsy syndrome	3.39e-06	4.26e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GPX1—epilepsy syndrome	3.15e-06	3.96e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—AGT—epilepsy syndrome	2.76e-06	3.47e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—APOE—epilepsy syndrome	2.71e-06	3.4e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—POMC—epilepsy syndrome	2.33e-06	2.92e-05	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—AKT1—epilepsy syndrome	2.3e-06	2.89e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PTGS2—epilepsy syndrome	1.86e-06	2.33e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—AKT1—epilepsy syndrome	9.33e-07	1.17e-05	CbGpPWpGaD
